International Collaborations

Promoting collaboration with international stakeholders in the HIV and other infectious diseases fields is a central theme in EuroVacc’s mission.

Agence nationale de recherches sur le sida et les hepatitis virales (ANRS)

EuroVacc together with ANRS (Agence nationale de recherches sur le sida et les hépatites virales) have co-sponsored the EV03/ANRSVAC20 trial. This is a phase II trial designed to generate further immunogenicity and safety data of the DNA-C prime and NYVAC-C boost regimen and to define the best immunization schedule.

EC Consortium: IDEA

Dissecting the Immunological Interplay between Poverty Related Diseases and Helminth Infections: An African-European Research Initiative (IDEA) is a project with 20 Sub-Sahara African and European consortium members and coordinated by the Centre Hospitalier Universitaire Vaudois. IDEA project will focus its efforts on four primary objectives: a) the worm-induced modulation of the functional and molecular profile of HIV-, TB- and malaria-specific immune responses, b) the impact by worm co-infections on measures of disease activity of PRDs, c) the immunologic markers of worm-, HIV-, TB- and malaria-specific immune responses associated with better control of pathogen replication and disease, and d) the modulation by worm co-infections of vaccine-induced immune responses. The project was launched in March 2010.

EuroVacc will contribute primarily to the last objective.